| Authors: |
Tang EY; Institute of Health and Society, Newcastle University Institute of Ageing, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom., Harrison SL; Institute of Health and Society, Newcastle University Institute of Ageing, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom., Errington L; Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom., Gordon MF; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut, 06877, United States of America., Visser PJ; Maastricht University, Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht, The Netherlands; VU University Medical Centre, Department of Neurology, Alzheimer Centre, Neuroscience Campus, Amsterdam, The Netherlands., Novak G; Janssen Pharmaceutical Research and Development, 1125 Trenton-Harbourton Road, Titusville, New Jersey, 08560, United States of America., Dufouil C; Inserm Research Centre (U897), Team Neuroepidemiology, F-33000, Bordeaux, France., Brayne C; Department of Public Health and Primary Care, Cambridge University, Cambridge, CB2 0SR, United Kingdom., Robinson L; Institute of Health and Society, Newcastle University Institute of Ageing, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom., Launer LJ; Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, National Institutes of Health (NIH), Bethesda, Maryland, United States of America., Stephan BC; Institute of Health and Society, Newcastle University Institute of Ageing, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom. |
